Salla Lahdenpohja is a senior researcher at the Turku PET Centre in Finland. She acst as a QC manager being responsible for analytical method development and maintenance. She has a Master of Science degree in Chemistry from University of Turku. Presently, Lahdenpohja is PhD candidate carrying out research with a title “Synthesis of ¹⁸F-labelled radiopharmaceuticals for the CNS”. In her thesis research she focuses on using transition metals in ¹⁸F-labelling reactions. Latest results have just been published! More about her thesis work can be read from the University of Turku Elävää tiedettä -blog (“Living science”, blog post only in Finnish).

ORCID iD: 0000-0003-2456-5009

Twitter: @LahdenpohjaS

e-mail: salla.lahdenpohja (a) utu.fi

Recent publications:

• Tolvanen T, Kalliokoski KK, Malaspina S, Kuisma A, Lahdenpohja S, Postema EJ, Miller MP, Scheinin M: Safety, biodistribution and radiation dosimetry of ¹⁸F-rhPSMA-7.3 in healthy adult volunteers, J Nucl Med, 2020, 6.
• Lahdenpohja S, Rajala N, Helin J, Haaparanta-Solin M, Solin O, López-Picón F, Kirjavainen AK: Ruthenium-Mediated ¹⁸F-Fluorination and Preclinical Evaluation of a New CB₁ Receptor Imaging Agent [¹⁸F]FPATPP, ACS Chem Neurosci, 2020, 11: 2009-2018.
• Lahdenpohja S, Keller T, Forsback S, Viljanen T, Kokkomäki E, Kivelä R V, Bergman J, Solin O, Kirjavainen AK: Automated GMP production and long-term experience in radiosynthesis of CB₁-tracer [¹⁸F]FMPEP-d₂, J Label Compd Radiopharm, 2020, 63: 408-418.
• Lahdenpohja S, Rajala N, Rajander J, Kirjavainen AK: Fast and efficient copper-mediated ¹⁸F‑fluorination of arylstannanes, aryl boronic acids, and aryl boronic esters without azeotropic drying, EJNMMI Radiopharm Chem, 2019, 4: 28.
• Lahdenpohja S, Keller T, Rajander J, Kirjavainen AK: Radiosynthesis of the norepinephrine transporter tracer [¹⁸F]NS12137 via copper‐mediated ¹⁸F‐labelling. J Label Compd Radiopharm, 2019, 62: 259-264.